These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6344623)

  • 1. The biologic background to some therapeutic uses of aspirin.
    Born GV; Görög P; Begent NA
    Am J Med; 1983 Jun; 74(6A):2-9. PubMed ID: 6344623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombophilia in patients with arterial occlusive diseases and its therapeutic modification].
    Norden C; Reimann H; Grunow G; Misselwitz F
    Vasa Suppl; 1991; 32():300-4. PubMed ID: 1771519
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-platelet aggregation action and paradoxical effects of acetylsalicylic acid].
    Mocchi N; Sbalzarini G; Cantaluppi P
    Clin Ter; 1985 Jul; 114(1):37-41. PubMed ID: 4042578
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-steroidal anti-inflammatory agents and coronary heart disease.
    Mustard JF; Packham MA; Kinlough-Rathbone RL
    Acta Med Scand Suppl; 1980; 642():180-90. PubMed ID: 6935944
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostaglandins, aspirin, and analgesia.
    Lancet; 1973 May; 1(7810):979. PubMed ID: 4121596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet drugs in arterial thrombosis: a review.
    Tsu EC
    Am J Hosp Pharm; 1978 Dec; 35(12):1507-15. PubMed ID: 362914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aspirin on hemostasis and thrombosis.
    Buchanan MR; Hirsh J
    N Engl Reg Allergy Proc; 1986; 7(1):26-31. PubMed ID: 3302653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
    Oelz O
    Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are agents affecting platelet functions clinically useful?
    Verstraete M
    Am J Med; 1976 Dec; 61(6):897-914. PubMed ID: 795299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of action of aspirin-like drugs.
    Moncada S; Vane JR
    Adv Intern Med; 1979; 24():1-22. PubMed ID: 371357
    [No Abstract]   [Full Text] [Related]  

  • 13. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS; Wharton KA; White BP; Lumley P
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin revisited.
    Rodvein R; Cooke AR
    Ser Haematol; 1975; 8(3):141-50. PubMed ID: 790585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acetylsalicylic acid on experimentally induced arterial thrombosis in rats.
    Meng K; Seuter F
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Dec; 301(2):115-9. PubMed ID: 600324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin as an antithrombotic drug: from the aggregometer to clinical trials.
    de Gaetano G
    Verh K Acad Geneeskd Belg; 1990; 52(6):459-71; discussion 471-3. PubMed ID: 2150736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.
    Turner NA; Moake JL; Kamat SG; Schafer AI; Kleiman NS; Jordan R; McIntire LV
    Circulation; 1995 Mar; 91(5):1354-62. PubMed ID: 7867173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental platelet aggregation and arterial thrombosis. Effect of aspirin].
    Bousser MG; Lecrubier C
    Nouv Presse Med; 1973 Jun; 2(25):1687-92. PubMed ID: 4718537
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; van Vliet HH
    Blood Cells Mol Dis; 2006; 36(2):199-205. PubMed ID: 16510297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy and progression of coronary artery disease. Antiplatelet versus antithrombins.
    Chesebro JH; Webster MW; Zoldhelyi P; Roche PC; Badimon L; Badimon JJ
    Circulation; 1992 Dec; 86(6 Suppl):III100-10. PubMed ID: 1424043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.